MicroVAX Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

MicroVAX General Information


Operator of a clinical biotechnology company intended to develop a cancer vaccine. The company is dedicated to the development of potent vaccines, for treatment and preventive purposes, having applications in the areas of cancer and infectious diseases for which effective solutions have not yet been developed, enabling medical professionals to treat patients in a better way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Angel backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Primary Office
  • 10900 Univesity Boulevard
  • Mason Enterprise Center MS 1J2
  • Manassas, VA 20110
  • United States
+1 (703) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MicroVAX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Jan-2023 00000 Completed Clinical Trials - Phase 1
2. Angel (individual) 13-Apr-2015 00000 00000 Completed Clinical Trials - Phase 1
1. Angel (individual) 22-Feb-2011 $22.5K $22.5K Completed Startup
To view MicroVAX’s complete valuation and funding history, request access »

MicroVAX Patents

MicroVAX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230241193-A1 Mrna vaccine design using multiple interacting immuno-stimulatory pathways, for cancer and infectious diseases Pending 03-Feb-2022 0000000000000
CA-3073992-A1 Combination cancer therapy Pending 01-Sep-2017 000000000000
US-20190070289-A1 Combination cancer therapy Pending 01-Sep-2017 000000000000
EP-3675891-A4 Combination cancer therapy Pending 01-Sep-2017 000000000000 0
EP-3675891-A1 Combination cancer therapy Pending 01-Sep-2017 A61K39/00117
To view MicroVAX’s complete patent history, request access »

MicroVAX Executive Team (1)

Name Title Board Seat Contact Info
Jacob Frank Chief Executive Officer, Managing Member & Principal
To view MicroVAX’s complete executive team members history, request access »